Market capitalization is the total value the stock market puts on a company: its share price multiplied by the number of shares outstanding. Each point here is the share count reported in a filing multiplied by the closing price on that filing date, adjusted for later stock splits, so the history moves when a new filing arrives rather than with each day's trading. A larger market cap means investors collectively value the company more highly; by itself it says nothing about profit or debt. Annual points keep the latest observation in each calendar year.
Edgewise Therapeutics, Inc. market cap for the quarter ending 2026-07-31 was $4.17B, a 177.49% increase year-over-year.
Edgewise Therapeutics, Inc. market cap for the quarter ending 2026-06-30 was $4.38B, a 217.55% increase year-over-year.
Edgewise Therapeutics, Inc. market cap for the quarter ending 2026-04-30 was $3.33B, a 93.14% increase year-over-year.
Edgewise Therapeutics, Inc. market cap for the quarter ending 2026-03-31 was $3.38B, a 61.54% increase year-over-year.
Edgewise Therapeutics, Inc. market cap for fiscal 2026 was $4.17B.
Edgewise Therapeutics, Inc. market cap for fiscal 2025 was $2.64B, a 4.08% increase from fiscal 2024.
Edgewise Therapeutics, Inc. market cap for fiscal 2024 was $2.53B, a 228.53% increase from fiscal 2023.
Edgewise Therapeutics, Inc. market cap for fiscal 2023 was $770.76M, a 36.29% increase from fiscal 2022.